Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6) (Middle Region) Peptide
Aperçu rapide pour Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6) (Middle Region) Peptide (ABIN8113287)
Antigène
Source
Application
-
-
Protein Region
- Middle Region
-
Fonction
- SSX6P Peptide - middle region
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-SSX6 antibody ( ARP36225_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- SSX6 (Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6))
-
Sujet
-
Background Information: This gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X;18) translocation characteristically found in all synovial sarcomas. This gene is classified as a pseudogene because a splice donor in the 3' UTR has changed compared to other family members, rendering the transcript a candidate for nonsense-mediated mRNA decay (NMD).
Alternative Symbols: SSX6, SSXP2, psiSSX2, dJ54B20.1
-
Poids moléculaire
- 22kDa
-
ID gène
- 280657
-
NCBI Accession
- NP_775493
-
UniProt
- Q7RTT6
Antigène
-